Afya Ltd (AFYA)vsCovista Inc. (CVSA)
AFYA
Afya Ltd
$15.16
-2.13%
CONSUMER DEFENSIVE · Cap: $1.37B
CVSA
Covista Inc.
$113.08
+3.14%
CONSUMER DEFENSIVE · Cap: $3.98B
Smart Verdict
WallStSmart Research — data-driven comparison
Afya Ltd generates 96% more annual revenue ($3.70B vs $1.89B). AFYA leads profitability with a 20.3% profit margin vs 13.4%. AFYA trades at a lower P/E of 9.7x. CVSA earns a higher WallStSmart Score of 67/100 (B-).
AFYA
Strong Buy66
out of 100
Grade: B-
CVSA
Strong Buy67
out of 100
Grade: B-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+68.3%
Fair Value
$48.86
Current Price
$15.16
$33.70 discount
Margin of Safety
N/A
Fair Value
$97.23
Current Price
$113.08
$15.85 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Attractively priced relative to earnings
Reasonable price relative to book value
Strong operational efficiency at 30.4%
Keeps 20 of every $100 in revenue as profit
Growing faster than its price suggests
Attractively priced relative to earnings
Reasonable price relative to book value
Strong operational efficiency at 22.9%
Areas to Watch
Smaller company, higher risk/reward
4.7% earnings growth
Comparative Analysis Report
WallStSmart ResearchBull Case : AFYA
The strongest argument for AFYA centers on P/E Ratio, Price/Book, Operating Margin. Profitability is solid with margins at 20.3% and operating margin at 30.4%.
Bull Case : CVSA
The strongest argument for CVSA centers on PEG Ratio, P/E Ratio, Price/Book. Revenue growth of 12.4% demonstrates continued momentum. PEG of 0.81 suggests the stock is reasonably priced for its growth.
Bear Case : AFYA
The primary concerns for AFYA are Market Cap.
Bear Case : CVSA
The primary concerns for CVSA are EPS Growth.
Key Dynamics to Monitor
AFYA profiles as a mature stock while CVSA is a value play — different risk/reward profiles.
CVSA carries more volatility with a beta of 0.73 — expect wider price swings.
CVSA is growing revenue faster at 12.4% — sustainability is the question.
AFYA generates stronger free cash flow (140M), providing more financial flexibility.
Bottom Line
CVSA scores higher overall (67/100 vs 66/100) and 12.4% revenue growth. AFYA offers better value entry with a 68.3% margin of safety. Both earn "Strong Buy" and "Strong Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Afya Ltd
CONSUMER DEFENSIVE · EDUCATION & TRAINING SERVICES · USA
Afya Limited, is a medical education group in Brazil. The company is headquartered in Nova Lima, Brazil.
Visit Website →Covista Inc.
CONSUMER DEFENSIVE · EDUCATION & TRAINING SERVICES · USA
Covista Inc., provides healthcare education in the United States, Barbados, St. Kitts, and St. Maarten. The company is headquartered in Chicago, Illinois.
Compare with Other EDUCATION & TRAINING SERVICES Stocks
Want to dig deeper into these stocks?